Characterization of the DOT1L Network: Implications of Diverse Roles for DOT1L

被引:0
|
作者
Geunyeong Park
Zihua Gong
Junjie Chen
Ja-Eun Kim
机构
[1] Kyung Hee University,Department of Pharmacology, School of Medicine
[2] The University of Texas M.D. Anderson Cancer Center,Department of Experimental Radiation Oncology
来源
The Protein Journal | 2010年 / 29卷
关键词
Affinity purification; AF9; DOT1L; ENL; NPM1;
D O I
暂无
中图分类号
学科分类号
摘要
Methylation of lysine 79 on histone H3 (H3K79) is mediated by a methyltransferase called Dot1-like protein (DOT1L). DOT1L is involved in the regulation of telomeric silencing, development, cell cycle checkpoint and transcription. However, the mechanisms by which DOT1L controls these unrelated and diverse functions are unknown. To gain greater insight into DOT1L-mediated functions, we have purified a DOT1L-containing complex using tandem affinity purification. Mass spectrometry of the DOT1L-containing complex revealed that AF9, ENL and NPM1 were shown to be major DOT1L-interacting proteins. To construct a plausible DOT1L-interaction web, AF9-, ENL- and NPM1-containing complexes were also purified for mass spectrometry analysis. The data showed that DOT1L might control AF9- and ENL-mediated transcription, regulate RNA processing, and function as a histone chaperone in a NPM1-dependent manner. In addition, the purification of protein complexes identified a number of novel interacting partners associated with DOT1L, AF9, ENL and NPM1. These data define a unique DOT1L network and shed light on unknown functions of the DOT1L complex.
引用
收藏
页码:213 / 223
页数:10
相关论文
共 50 条
  • [41] Essential role of DOT1L in maintaining normal adult hematopoiesis
    Anh T Nguyen
    Jin He
    Olena Taranova
    Yi Zhang
    Cell Research, 2011, 21 : 1370 - 1373
  • [42] Cancer cell proliferation regulated by DOT1L histone methyltransferase
    Kim, W.
    Kim, R.
    Park, G.
    Kim, J.
    MOLECULAR BIOLOGY OF THE CELL, 2011, 22
  • [43] DOT1L inhibition activates immunologic signatures in multiple myeloma
    Ishiguro, Kazuya
    Kitajima, Hiroshi
    Niinuma, Takeshi
    Maruyama, Reo
    Kumegawa, Kohei
    Sekiguchi, Shohei
    Kai, Masahiro
    Nakase, Hiroshi
    Suzuki, Hiromu
    CANCER SCIENCE, 2023, 114 : 561 - 561
  • [44] Increased DOT1L in synovial biopsies of patients with OA and RA
    He, Dongyi
    Liu, Jia
    Hai, Yamei
    Zhu, Qi
    Shen, Yu
    Guo, Shicheng
    Zhang, Wenzheng
    Zhou, Xiaodong
    CLINICAL RHEUMATOLOGY, 2018, 37 (05) : 1327 - 1332
  • [45] DOT1L bridges transcription and heterochromatin formation at mammalian pericentromeres
    Malla, Aushaq B.
    Yu, Haoming
    Farris, Delaney
    Kadimi, Srilekha
    Lam, TuKiet T.
    Cox, Andy L.
    Smith, Zachary D.
    Lesch, Bluma J.
    EMBO REPORTS, 2023, 24 (08)
  • [46] DOT1L is a barrier to histone acetylation during reprogramming to pluripotency
    Wille, Coral K.
    Zhang, Xiaoya
    Haws, Spencer A.
    Denu, John M.
    Sridharan, Rupa
    SCIENCE ADVANCES, 2023, 9 (46)
  • [47] New Potent DOT1L Inhibitors for in Vivo Evaluation in Mouse
    Stauffer, Frederic
    Weiss, Andreas
    Scheufler, Clemens
    Moebitz, Henrik
    Ragot, Christian
    Beyer, Kim S.
    Calkins, Keith
    Guthy, Daniel
    Kiffe, Michael
    Van Eerdenbrugh, Bernard
    Tiedt, Ralph
    Gaul, Christoph
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (12): : 1655 - 1660
  • [48] Aldosterone inhibits Dot1l expression in guinea pig cochlea
    Shixun Zhong
    Biyun Zhang
    Li Qin
    Qianying Wang
    Xiaoli Luo
    European Journal of Medical Research, 28
  • [49] Targeting Recruitment of Disruptor of Telomeric Silencing 1-like (DOT1L) CHARACTERIZING THE INTERACTIONS BETWEEN DOT1L AND MIXED LINEAGE LEUKEMIA (MLL) FUSION PROTEINS
    Shen, Chenxi
    Jo, Stephanie Y.
    Liao, Chenzhong
    Hess, Jay L.
    Nikolovska-Coleska, Zaneta
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (42) : 30585 - 30596
  • [50] DOT1L IS A THERAPEUTIC TARGET IN MIXED-LINEAGE LEUKEMIA
    不详
    CANCER DISCOVERY, 2011, 1 (03) : 196 - 197